{"schema_version":"secwatch.filing_event.v1","accession":"0001493152-26-031124","form_type":"8-K","ticker":"OTLC","cik":"0000908259","company_name":"Oncotelic Therapeutics, Inc.","filed_at":"2026-06-29T21:15:16+00:00","discovered_at":"2026-06-29T21:16:00.317577+00:00","generated_at":"2026-06-29T21:16:23.159122+00:00","sec_items":["1.01","2.03","3.02","9.01"],"event_type":"debt","sentiment":"neutral","materiality_score":0.4,"calibrated_materiality_score":0.4,"confidence":"high","headline":"Oncotelic enters $178K convertible note financing with Pacific Pier Capital","bullets":["Issued $178,410 convertible promissory note with 12% OID and 12% interest, maturing in 1 year.","Conversion price: $0.06/share or 85% of lowest VWAP in prior 10 trading days.","Net proceeds to Oncotelic ~$150,000 after buyer's $7,000 legal fee withholding.","Issued 500,000 commitment shares as additional consideration to Pacific Pier.","Prepayment allowed after 6 months; default interest rate of 16% upon event of default."],"urls":{"canonical":"https://secwatch.observer/filing/0001493152-26-031124","json":"https://secwatch.observer/filing/0001493152-26-031124.json","markdown":"https://secwatch.observer/filing/0001493152-26-031124.md","text":"https://secwatch.observer/filing/0001493152-26-031124.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/908259/000149315226031124/0001493152-26-031124-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/908259/000149315226031124/form8-k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-29T21:16:23.159122+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}